We are live on ! Find out more
TI

Turner Investments Portfolio holdings

AUM $134K
1-Year Est. Return 49.03%
This Fund
S&P 500
This Quarter Est. Return
+0.63%
1 Year Est. Return
-49.03%
3 Year Est. Return
+6.36%
5 Year Est. Return
+75.79%
10 Year Est. Return
AUM
$369M
AUM Growth
-$114M
Cap. Flow
-$97.1M
Cap. Flow %
-26.31%
Top 10 Hldgs %
18.38%
Holding
302
New
88
Increased
47
Reduced
69
Closed
95

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$6.93M
2
NVS icon
Novartis
NVS
+$6.11M
3
APTV icon
Aptiv
APTV
+$5.73M
4
BFH icon
Bread Financial
BFH
+$5.18M
5
NBR icon
Nabors Industries
NBR
+$4.96M

Sector Composition

Rank Sector Weight
1 Healthcare 31%
2 Technology 24.95%
3 Industrials 8.8%
4 Consumer Discretionary 8.28%
5 Communication Services 7.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EEFT icon
226
Euronet Worldwide
EEFT
$2.67B
-21,000
Closed -$1.52M
EOG icon
227
EOG Resources
EOG
$71B
-14,000
Closed -$991K
GILD icon
228
Gilead Sciences
GILD
$166B
-33,650
Closed -$3.4M
GWRE icon
229
Guidewire Software
GWRE
$14.1B
-20,500
Closed -$1.23M
HCSG icon
230
Healthcare Services Group
HCSG
$1.54B
-14,000
Closed -$488K
HTHT icon
231
Huazhu Hotels Group
HTHT
$13B
-120,000
Closed -$938K
IMAX icon
232
IMAX
IMAX
$2.68B
-49,525
Closed -$1.76M
IRWD icon
233
Ironwood Pharmaceuticals
IRWD
$711M
-125,191
Closed -$1.22M
LAD icon
234
Lithia Motors
LAD
$8.22B
-8,750
Closed -$933K
HAPN
235
Happen Inc
HAPN
$2.24B
-3,000
Closed -$166K
LYB icon
236
LyondellBasell Industries
LYB
$19.5B
-12,000
Closed -$963K
MIDD icon
237
Middleby
MIDD
$6.08B
-1,250
Closed -$135K
NBIX icon
238
Neurocrine Biosciences
NBIX
$16.6B
-18,000
Closed -$1.02M
NBR icon
239
Nabors Industries
NBR
$1.22B
-11,666
Closed -$4.96M
NHTC icon
240
Natural Health Trends
NHTC
$15.8M
-50,000
Closed -$1.68M
NKE icon
241
Nike
NKE
$62B
-4,220
Closed -$255K
NOC icon
242
Northrop Grumman
NOC
$81B
-4,900
Closed -$925K
OZK icon
243
Bank OZK
OZK
$5.64B
-98,280
Closed -$4.86M
PCRX icon
244
Pacira BioSciences
PCRX
$1B
-8,000
Closed -$614K
PCTY icon
245
Paylocity
PCTY
$8.05B
-35,000
Closed -$1.42M
PTCT icon
246
PTC Therapeutics
PTCT
$6.03B
-47,280
Closed -$1.53M
PTEN icon
247
Patterson-UTI
PTEN
$3.83B
-46,000
Closed -$694K
REGN icon
248
Regeneron Pharmaceuticals
REGN
$80.4B
-6,290
Closed -$3.41M
RH icon
249
RH
RH
$3.69B
-750
Closed -$60K
RIGL icon
250
Rigel Pharmaceuticals
RIGL
$752M
-28,502
Closed -$864K

Similar funds

Turner Investments's Q1 2016 Portfolio in Review

As of Q1 2016, Turner Investments held 302 positions worth $369M, down 24% from $483M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Turner Investments withdrew a net $97.1M in Q1 2016, closing 95 positions and reducing 69 holdings. Its most notable exit was Aptiv, an estimated $5.73M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 36% a quarter earlier, followed by Technology and Industrials.

Against the trend, Turner Investments opened a new position in Edwards Lifesciences worth $4.87M.

  • Turner Investments's largest Q1 2016 buy was Edwards Lifesciences: 165,450 shares worth $4.87M.
  • Turner Investments added most to SolarEdge in Q1 2016, an estimated $4.14M increase.
  • Turner Investments's biggest Q1 2016 reduction was Eli Lilly, cutting an estimated $6.93M.
  • Turner Investments fully exited Aptiv in Q1 2016, selling an estimated $5.73M.
  • Turner Investments's ten largest holdings make up 18% of its $369M portfolio in Q1 2016.
  • Turner Investments opened 88 new positions and closed 95 in Q1 2016.
  • Turner Investments's portfolio value fell 24% quarter-over-quarter to $369M.

Based on Turner Investments's 13F filing for Q1 2016, filed 13 May 2016.